azenta inc. - AZTA

AZTA

Close Chg Chg %
27.00 0.72 2.67%

Closed Market

27.72

+0.72 (2.67%)

Volume: 1.11M

Last Updated:

May 27, 2025, 4:00 PM EDT

Company Overview: azenta inc. - AZTA

AZTA Key Data

Open

$27.78

Day Range

27.31 - 27.97

52 Week Range

23.98 - 63.58

Market Cap

$1.24B

Shares Outstanding

45.78M

Public Float

44.86M

Beta

1.64

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.41

Yield

0.00%

Dividend

$0.10

EX-DIVIDEND DATE

Dec 2, 2021

SHORT INTEREST

N/A

AVERAGE VOLUME

1.01M

 

AZTA Performance

1 Week
 
2.67%
 
1 Month
 
3.70%
 
3 Months
 
-36.45%
 
1 Year
 
-45.58%
 
5 Years
 
-30.65%
 

AZTA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About azenta inc. - AZTA

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

AZTA At a Glance

Azenta, Inc.
200 Summit Drive
Burlington, Massachusetts 01803
Phone 1-978-262-2400 Revenue 656.32M
Industry Medical/Nursing Services Net Income -164,170,000.00
Sector Health Services Employees 3,300
Fiscal Year-end 09 / 2025
View SEC Filings

AZTA Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 3.925
Price to Book Ratio 1.248
Price to Cash Flow Ratio 51.22
Enterprise Value to EBITDA 122.265
Enterprise Value to Sales 3.325
Total Debt to Enterprise Value 0.032

AZTA Efficiency

Revenue/Employee 198,885.758
Income Per Employee -49,748.485
Receivables Turnover 3.251
Total Asset Turnover 0.263

AZTA Liquidity

Current Ratio 4.066
Quick Ratio 3.503
Cash Ratio 2.266

AZTA Profitability

Gross Margin 36.09
Operating Margin -11.107
Pretax Margin -25.494
Net Margin -25.014
Return on Assets -6.586
Return on Equity -7.63
Return on Total Capital -8.924
Return on Invested Capital -7.419

AZTA Capital Structure

Total Debt to Total Equity 3.995
Total Debt to Total Capital 3.842
Total Debt to Total Assets 3.365
Long-Term Debt to Equity 3.399
Long-Term Debt to Total Capital 3.269
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Azenta Inc. - AZTA

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
513.70M 555.50M 665.07M 656.32M
Sales Growth
-42.75% +8.14% +19.73% -1.32%
Cost of Goods Sold (COGS) incl D&A
299.19M 324.88M 431.82M 419.46M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
56.87M 53.70M 85.58M 90.74M
Depreciation
19.50M 21.41M 37.21M 39.47M
Amortization of Intangibles
37.37M 32.29M 48.38M 51.27M
COGS Growth
-45.37% +8.59% +32.92% -2.86%
Gross Income
214.51M 230.62M 233.26M 236.87M
Gross Income Growth
-38.63% +7.51% +1.14% +1.55%
Gross Profit Margin
+41.76% +41.52% +35.07% +36.09%
2021 2022 2023 2024 5-year trend
SG&A Expense
210.91M 254.64M 315.45M 309.76M
Research & Development
22.41M 27.54M 33.96M 33.52M
Other SG&A
188.50M 227.10M 281.50M 276.24M
SGA Growth
-19.20% +20.73% +23.88% -1.80%
Other Operating Expense
- - - -
-
Unusual Expense
34.69M 1.34M (9.07M) 127.78M
EBIT after Unusual Expense
(31.09M) (25.37M) (73.13M) (200.68M)
Non Operating Income/Expense
(15.84M) 20.02M 42.69M 33.35M
Non-Operating Interest Income
632.00K 20.29M 43.73M 33.18M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - 2.04M 4.59M
-
Interest Expense Growth
- - -30.81% +125.28%
-
Gross Interest Expense
- - 2.04M 4.59M
-
Interest Capitalized
- - - -
-
Pretax Income
(48.97M) (9.94M) (30.43M) (167.32M)
Pretax Income Growth
-165.32% +79.71% -206.29% -449.81%
Pretax Margin
-9.53% -1.79% -4.58% -25.49%
Income Tax
(20.10M) 1.35M (17.55M) (3.15M)
Income Tax - Current - Domestic
(15.11M) (4.22M) 929.00K 1.71M
Income Tax - Current - Foreign
15.48M 4.63M 9.76M 11.22M
Income Tax - Deferred - Domestic
(13.75M) (995.00K) (19.09M) (5.14M)
Income Tax - Deferred - Foreign
(6.72M) 1.94M (9.15M) (10.94M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(28.87M) (11.29M) (12.88M) (164.17M)
Minority Interest Expense
- - - -
-
Net Income
(28.87M) (11.29M) (12.88M) (164.17M)
Net Income Growth
-144.39% +60.91% -14.15% -1,174.31%
Net Margin Growth
-5.62% -2.03% -1.94% -25.01%
Extraordinaries & Discontinued Operations
- 139.62M (417.68M) (1.37M)
Discontinued Operations
- 139.62M (417.68M) (1.37M)
Net Income After Extraordinaries
110.75M (428.96M) (14.26M) (164.17M)
Preferred Dividends
- - - -
-
Net Income Available to Common
110.75M (428.96M) (14.26M) (164.17M)
EPS (Basic)
1.492 -5.7274 -0.2152 -3.0873
EPS (Basic) Growth
+69.22% -483.87% +96.24% -1,334.62%
Basic Shares Outstanding
74.23M 74.90M 66.25M 53.17M
EPS (Diluted)
1.4874 -5.7274 -0.2152 -3.0873
EPS (Diluted) Growth
+69.37% -485.06% +96.24% -1,334.62%
Diluted Shares Outstanding
74.45M 74.90M 66.25M 53.17M
EBITDA
60.47M 29.68M 3.39M 17.85M
EBITDA Growth
-60.74% -50.92% -88.59% +427.14%
EBITDA Margin
+11.77% +5.34% +0.51% +2.72%

Snapshot

Average Recommendation HOLD Average Target Price 29.60
Number of Ratings 7 Current Quarters Estimate 0.127
FY Report Date 06 / 2025 Current Year's Estimate 0.43
Last Quarter’s Earnings 0.05 Median PE on CY Estimate N/A
Year Ago Earnings 0.41 Next Fiscal Year Estimate 0.806
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 7 7
Mean Estimate 0.13 0.18 0.43 0.81
High Estimates 0.17 0.24 0.53 0.99
Low Estimate 0.09 0.13 0.35 0.53
Coefficient of Variance 25.57 20.81 15.48 18.00

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 2
OVERWEIGHT 0 0 0
HOLD 5 5 5
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Hold Hold Hold

Insider Actions for Azenta Inc. - AZTA

Date Name Shares Transaction Value
May 21, 2025 William Lindsay Cornog Director 14,855 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $26.5 per share 393,657.50
May 21, 2025 William Lindsay Cornog Director 19,007 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $26.98 per share 512,808.86
May 21, 2025 William Lindsay Cornog Director 21,755 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $27.37 per share 595,434.35
Nov 8, 2024 Quentin George Koffey Director 995 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Azenta Inc. in the News

OSZAR »